Arkolith/Insider Trading/MLYS/Form 4

Rodman David Malcom

Chief Medical OfficerMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Mar 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$58K
Net Open-Market Flow
-$58K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 9, 2026Option exercise(M)2K$16.00$35K85K
Mar 9, 2026Sell(S)2K$26.84$58K82K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 9, 2026Option exercise(M)2K—$024K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001672659-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML